Showing results (41-50 of 115) with videos related to
Sort By:
Pageof 12
Critical Reviews in Oncology/Hematology|March 1, 2011
Anticancer evidence for zoledronic acid across the cancer continuumLuis Costa, Peter Harper, Robert E Coleman, et al.Current Oncology Reports|February 14, 2021
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed DrugsNalinie Joharatnam-Hogan, Leo Alexandre, James Yarmolinsky, et al.JBI Library of Systematic Reviews|November 8, 2016
A comprehensive systematic review of the use of simulation in the continuing education and training of qualified medical, nursing and midwifery staffSharon Elliott, Karen Murrell, Peter Harper, et al.Aerospace Medicine and Human Performance|July 11, 2025
Psychological Adaptation in a Mixed Sex and Ability Team During a Ski Expedition to the South PolePeter Harper, Nadja Albertsen, Fiona Koivula, et al.Journal of Geriatric Oncology|February 6, 2014
Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging?Athanasios G Pallis, Sigrid Hatse, Barbara Brouwers, et al.Journal of Racial and Ethnic Health Disparities|September 17, 2025
Exploring Rurality and Racial/Ethnic Disparities in Texas Mortality: A Scoping Review of the Five Leading Causes of DeathGogoal Falia, Emesomhi Eboreime, Peter Harper, et al.JACC. Cardiooncology|July 12, 2022
Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies: A National Registry Dataset AnalysisNicolò Matteo Luca Battisti, Catherine A Welch, Michael Sweeting, et al.Trials|May 7, 2022
Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancerClaire Snowdon, Sarah Kernaghan, Laura Moretti, et al.Breast (Edinburgh, Scotland)|February 8, 2022
Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trialPaul Cottu, Alistair Ring, Hikmat Abdel-Razeq, et al.The Breast Journal|August 24, 2017
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experienceAlicia Okines, Tazia Irfan, Komel Khabra, et al.Pageof 12